Modernizing Medicine and its largest investor, Warburg Pincus, are evaluating a partial-stake sale of the specialty electronic health records giant, sources familiar with the matter tell Axios.
Why it matters: ModMed, along with Blackstone's HealthEdge Software, will represent a good test case for the new valuation reality in health tech investing if a deal gets done. It's been several months since we've seen scaled, growth-oriented SaaS companies test the market.
